- Home
- Innovation
Innovation
How drones are being used to deliver lifesaving HIV drugs to remote areas of the world
Normally, in this part of Uganda, medication is delivered by boat—a slow, difficult process. But now a new Johnson & Johnson-supported program is using drones that can serve 20 landing sites across five islands, reaching more than 3,700 people in a single day.
3 cutting-edge eye lenses designed to help improve how you see
Multifocal contacts based on your pupil size. Intraocular lenses that adapt to our digital world. These are just some of the new Johnson & Johnson advances poised to change the future of vision care.
How Johnson & Johnson has pioneered in the battle against HIV/AIDS
For World AIDS Day, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.
What to know about HDFN, a serious blood disorder in babies, including a possible new treatment
Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That’s why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.
The quest to help patients with a deadly type of lung cancer
Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. For Lung Cancer Awareness Month, they share their journey.
5 impactful ways Johnson & Johnson supports nurses and the incredible work they do
From mental health and resilience programs to Hackathons to essential podcasts, here are a few recent ways the company is championing frontline workers.
2 pandemics, 1 goal: Meet 4 innovators with high-tech ideas for fighting tuberculosis in the time of COVID-19
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who’ve made it their mission to move the world closer to the goal of ending tuberculosis.
4 things scientists now know about autoimmune diseases in kids
Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.
Johnson & Johnson Chairman and CEO appears at the White House to discuss the company’s collaboration with Merck and future vaccine production
Learn more about the event, Johnson & Johnson’s historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.
4 things we now know about the rare disease AL amyloidosis
Imagine having a disease that many doctors have never seen before. That’s what Marty Verel experienced when he was told he had AL amyloidosis—and it’s what hematologist Brendan Weiss, M.D., is determined to help change. For Rare Disease Day, Dr. Weiss shares what he’s learned studying the rare disease.